コンテンツぞスキップ
Merck

437725

Lipoxin A4, 15-epi

Lipoxin A4, 15-epi, CAS 171030-11-8, is an epimeric lipoxin A4 (Cat. No. 437720) analog that is more potent and metabolically stable than LXA4.

別名:

Lipoxin A4, 15-epi, LXA4-15-epi, 15( R)-LXA4, Aspirin-triggered LXA4, (5 S,6 R,15 R)-5,6,15-Trihydroxy-7,9,13- trans-11- cis-eicosatetraenoic acid, LXA4-15-epi, 15(R)-LXA4, Aspirin-triggered LXA4, (5S,6R,15R)-5,6,15-Trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid

ログむンで組織・契玄䟡栌をご芧ください。

サむズを遞択しおください

衚瀺を倉曎する

この商品に぀いお

実隓匏ヒル衚蚘法:
C20H32O5
CAS番号:
分子量:
352.47
MDL number:
UNSPSC Code:
12352211
NACRES:
NA.77
Assay:
≥98% (HPLC)
Form:
liquid
Storage condition:
OK to freeze, desiccated (hygroscopic), protect from light
テクニカルサヌビス
お困りのこずがあれば、経隓豊富なテクニカルサヌビスチヌムがお客様をサポヌトしたす。
お手䌝いしたす


Quality Segment

assay

≥98% (HPLC)

form

liquid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze, desiccated (hygroscopic), protect from light

shipped in

wet ice

storage temp.

−70°C

SMILES string

OC(C(O)\C=C\C=C\C=C\C=C\C(O)CCCCC)CCCC(=O)O

InChI

1S/C20H32O5/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18(22)19(23)15-11-16-20(24)25/h4-7,9-10,13-14,17-19,21-23H,2-3,8,11-12,15-16H2,1H3,(H,24,25)/b6-4+,7-5+,13-9+,14-10+

InChI key

IXAQOQZEOGMIQS-CRSXNMAESA-N

General description

A epimeric lipoxin A4 (Cat. No. 437720) analog that is more potent and metabolically stable than LXA4. Exhibits anti-inflammatory properties and serves as a "stop signal" to excessive leukocyte trafficking/infiltration. Blocks TNF-α-induced IL-8 release in human enterocyte. It is also an important modulator of the many pharmacological actions caused by aspirin.
An epimeric lipoxin A4 (Cat. No. 437720) analog that is more potent and metabolically stable than LXA4. Exhibits anti-inflammatory properties and serves as a "stop signal" to excessive leukocyte trafficking/infiltration. Reported to block TNF-α-induced IL-8 release in human enterocytes. Also reported to be an important modulator of the pharmacological actions of aspirin.



Caution! Product contains volatile liquid; keep cold at all times.
Caution! Product contains volatile liquid. Keep product cold at all times.

Biochem/physiol Actions

Cell permeable: no
Primary Target
Exhibits anti-inflammatory properties
Product does not compete with ATP.
Reversible: no

Packaging

Packaged under inert gas

Physical form

In Ethanol.

Preparation Note

Following initial thaw aliquot and freeze (-70°C).

Other Notes

Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
Wallace, J.L., and Fiorucci, S. 2003. Trends Pharmacol. Sci.24, 323.
Filep, J.G., et al. 2002. Adv. Exp. Med. Biol.507, 223.
Titos, E., et al. 1999. Am. J. Physiol.277, C870.
Gronert, K., et al. 1998. J. Exp. Med.187, 1285.
Maddox, J.F., et al. 1997. J. Biol. Chem.272, 6972.
Claria, J., et al. 1996. Mol. Med.2, 583.
Claria, J., and Serhan, C.N. 1995. Proc. Natl. Acad. Sci. USA92, 9475.
Serhan, C.N., et al. 1995. Biochemistry34, 14609.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Flammable (J)


ピクトグラム

FlameExclamation mark

泚意喚起語

Danger

ハザヌドコヌド

Hazard Classifications

Eye Irrit. 2 - Flam. Liq. 2

保管分類

3 - Flammable liquids

䞀䜓䜕が起きおいるの

WGK 1

匕火点 (F)

55.4 °F

匕火点°C

13 °C


適甚法什

詊隓研究甚途を考慮した関連法什を䞻に挙げおおりたす。化孊物質以倖に぀いおは、䞀郚の情報のみ提䟛しおいたす。 補品を安党か぀合法的に䜿甚するこずは、䜿甚者の矩務です。最新情報により修正される堎合がありたす。WEBの反映には時間を芁するこずがあるため、適宜SDSをご参照ください。

Group 4: Flammable liquids + Alcohols + Hazardous rank II

fsl

Substances Subject to be Indicated Names

ishl_indicated

Substances Subject to be Notified Names

ishl_notified



最新バヌゞョンのいずれかを遞択しおください

詊隓成瞟曞COA

Lot/Batch Number

適切なバヌゞョンが芋぀かりたせんか。

特定のバヌゞョンが必芁な堎合は、ロット番号たたはバッチ番号で特定の蚌明曞を怜玢できたす。

以前この補品を賌入いただいたこずがある堎合

文曞ラむブラリで、最近賌入した補品の文曞を怜玢できたす。

文曞ラむブラリにアクセスする